Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 689

Sort by

Sort Order Select

Journal Articles

The p21 Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO

Luke F. Peterson, Ming Yan, Dong-Er Zhang

Blood (2007) 109 (10): 4392–4398.

https://doi.org/10.1182/blood-2006-03-012575

Published: 2007

Journal Articles

Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation

Yun Dai, Payal Khanna, Shuang Chen, Xin-Yan Pei, Paul Dent, Steven Grant

Blood (2007) 109 (10): 4415–4423.

https://doi.org/10.1182/blood-2006-09-047076

Published: 2007

Journal Articles

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

Francois Guilhot, Jane Apperley, Dong-Wook Kim, Eduardo O. Bullorsky, Michele Baccarani, Gail J. Roboz, Sergio Amadori, Carmino A. de Souza, Jeffrey H. Lipton, Andreas Hochhaus, Dominik Heim, Richard A. Larson, Susan Branford, Martin C. Muller, Prasheen Agarwal, Ashwin Gollerkeri, Moshe Talpaz

Blood (2007) 109 (10): 4143–4150.

https://doi.org/10.1182/blood-2006-09-046839

Published: 2007

Journal Articles

The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia

Shuchi Agrawal, Wolf-Karsten Hofmann, Nicola Tidow, Mathias Ehrich, Dirk van den Boom, Steffen Koschmieder, Wolfgang E. Berdel, Hubert Serve, Carsten Müller-Tidow

Blood (2007) 109 (9): 3895–3905.

https://doi.org/10.1182/blood-2006-08-040147

Published: 2007

Includes: Supplemental data

Journal Articles

Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis

Guang Jin, Yukari Yamazaki, Miki Takuwa, Tomoko Takahara, Keiko Kaneko, Takeshi Kuwata, Satoshi Miyata, Takuro Nakamura

Blood (2007) 109 (9): 3998–4005.

https://doi.org/10.1182/blood-2006-08-041202

Published: 2007

Includes: Supplemental data

Journal Articles

MEK1/2 inhibitors sensitize Bcr/Abl + human leukemia cells to the dual Abl/Src inhibitor BMS-354/825

Tri K. Nguyen, Mohamed Rahmani, Hisashi Harada, Paul Dent, Steven Grant

Blood (2007) 109 (9): 4006–4015.

https://doi.org/10.1182/blood-2006-09-045039

Published: 2007

Journal Articles

Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage

Jennifer A. Cain, Zhifu Xiang, Julie O'Neal, Friederike Kreisel, AnnaLynn Colson, Hui Luo, Lothar Hennighausen, Michael H. Tomasson

Blood (2007) 109 (9): 3906–3914.

https://doi.org/10.1182/blood-2006-07-036335

Published: 2007

Includes: Supplemental data

Journal Articles

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

Blood (2007) 109 (8): 3489–3495.

https://doi.org/10.1182/blood-2006-08-040410

Published: 2007

Includes: Supplemental data

Journal Articles

ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia

Blood (2007) 109 (8): 3400–3408.

https://doi.org/10.1182/blood-2006-06-029579

Published: 2007

Includes: Supplemental data

Journal Articles

Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions

Kulandayan K. Subramanian, Yonghui Jia, Daocheng Zhu, Benjamin T. Simms, Hakryul Jo, Hidenori Hattori, Jian You, Joseph P. Mizgerd, Hongbo R. Luo

Blood (2007) 109 (9): 4028–4037.

https://doi.org/10.1182/blood-2006-10-055319

Published: 2007

Includes: Multimedia, Supplemental data

Journal Articles

Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells

Geoffrey A. Bartholomeusz, Moshe Talpaz, Vaibhav Kapuria, Ling Yuan Kong, Shimei Wang, Zeev Estrov, Waldemar Priebe, Ji Wu, Nicholas J. Donato

Blood (2007) 109 (8): 3470–3478.

https://doi.org/10.1182/blood-2006-02-005579

Published: 2007

Journal Articles

A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy

Anita Boyapati, Ming Yan, Luke F. Peterson, Joseph R. Biggs, Michelle M. Le Beau, Dong-Er Zhang

Blood (2006) 109 (9): 3963–3971.

https://doi.org/10.1182/blood-2006-09-045583

Published: 2006

Includes: Supplemental data

Journal Articles

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

Guang-Biao Zhou, Hui Kang, Lan Wang, Li Gao, Ping Liu, Jun Xie, Feng-Xiang Zhang, Xiang-Qin Weng, Zhi-Xiang Shen, Jue Chen, Long-Jun Gu, Ming Yan, Dong-Er Zhang, Sai-Juan Chen, Zhen-Yi Wang, Zhu Chen

Blood (2006) 109 (8): 3441–3450.

https://doi.org/10.1182/blood-2006-06-032250

Published: 2006

Includes: Supplemental data

Journal Articles

Integrated molecular profiling of SOD2 expression in multiple myeloma

Elaine M. Hurt, Suneetha B. Thomas, Benjamin Peng, William L. Farrar

Blood (2006) 109 (9): 3953–3962.

https://doi.org/10.1182/blood-2006-07-035162

Published: 2006

Includes: Supplemental data

Journal Articles

Pre-TCR expression cooperates with TEL-JAK2 to transform immature thymocytes and induce T-cell leukemia

Nuno R. dos Santos, David S. Rickman, Aurélien de Reynies, Françoise Cormier, Maryvonne Williame, Camille Blanchard, Marc-Henri Stern, Jacques Ghysdael

Blood (2006) 109 (9): 3972–3981.

https://doi.org/10.1182/blood-2006-09-048801

Published: 2006

Includes: Supplemental data

Journal Articles

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

Stephane Picard, Karine Titier, Gabriel Etienne, Emmanuelle Teilhet, Dominique Ducint, Marie-Agnes Bernard, Regis Lassalle, Gerald Marit, Josy Reiffers, Bernard Begaud, Nicholas Moore, Mathieu Molimard, Francois-Xavier Mahon

Blood (2006) 109 (8): 3496–3499.

https://doi.org/10.1182/blood-2006-07-036012

Published: 2006

Journal Articles

CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus

Ling Zhao, Jennifer L. Cannons, Stacie Anderson, Martha Kirby, Liping Xu, Lucio H. Castilla, Pamela L. Schwartzberg, Rémy Bosselut, P. Paul Liu

Blood (2006) 109 (8): 3432–3440.

https://doi.org/10.1182/blood-2006-10-051508

Published: 2006

Includes: Supplemental data

Journal Articles

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis

Jorge Cortes, Philippe Rousselot, Dong-Wook Kim, Ellen Ritchie, Nelson Hamerschlak, Steven Coutre, Andreas Hochhaus, Francois Guilhot, Giuseppe Saglio, Jane Apperley, Oliver Ottmann, Neil Shah, Philipp Erben, Susan Branford, Prasheen Agarwal, Ashwin Gollerkeri, Michele Baccarani

Blood (2006) 109 (8): 3207–3213.

https://doi.org/10.1182/blood-2006-09-046888

Published: 2006

Journal Articles

A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5

Marina Bousquet, Cyril Broccardo, Cathy Quelen, Fabienne Meggetto, Emilienne Kuhlein, Georges Delsol, Nicole Dastugue, Pierre Brousset

Blood (2006) 109 (8): 3417–3423.

https://doi.org/10.1182/blood-2006-05-025221

Published: 2006

Includes: Supplemental data

Journal Articles

Syk-dependent mTOR activation in follicular lymphoma cells

Ludivine Leseux, Safouane M. Hamdi, Talal al Saati, Florence Capilla, Christian Recher, Guy Laurent, Christine Bezombes

Blood (2006) 108 (13): 4156–4162.

https://doi.org/10.1182/blood-2006-05-026203

Published: 2006

NARROW

The p21 Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO

Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia

Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis

MEK1/2 inhibitors sensitize Bcr/Abl + human leukemia cells to the dual Abl/Src inhibitor BMS-354/825

Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia

Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions

Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells

A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy

Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo

Integrated molecular profiling of SOD2 expression in multiple myeloma

Pre-TCR expression cooperates with TEL-JAK2 to transform immature thymocytes and induce T-cell leukemia

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis

A novel PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5

Syk-dependent mTOR activation in follicular lymphoma cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only